ALI MOUSSA, M.D.
Hematology & Oncology Physician · TULSA, OK
Individual Active NPI 1548207814
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,290 | 211,440 | $12,333,095 | $4,846,325 | $3,869,217 |
| 2023 | 1,161 | 164,331 | $10,375,273 | $3,837,279 | $3,056,701 |
| 2022 | 1,198 | 161,492 | $9,422,630 | $3,603,144 | $2,879,341 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 18,000 | $1 | $1 |
| J9299 | Injection, nivolumab, 1 mg | 17,000 | $31 | $25 |
| J9271 | Injection, pembrolizumab, 1 mg | 14,600 | $56 | $45 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 11,350 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 9,420 | $0 | $0 |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | 8,600 | $5 | $4 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 7,000 | $0 | $0 |
| J0185 | Injection, aprepitant, 1 mg | 6,630 | $2 | $1 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 5,580 | $49 | $39 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 5,200 | $3 | $2 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 4,620 | $26 | $20 |
| Q5126 | Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg | 3,840 | $57 | $45 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 21439 | OK |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Oklahoma
- NPI 1386696011
- NPI 1669745667
- NPI 1932765088
- NPI 1447606348
- NPI 1205877974
- NPI 1003859679
- NPI 1336406685
- NPI 1609820034
See all Hematology & Oncology Physician providers in Oklahoma →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.